HomeORIC • NASDAQ
add
ORIC Pharmaceuticals Inc
Previous close
$10.98
Year range
$3.90 - $14.93
Market cap
1.07B USD
Avg Volume
1.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.67M | -4.30% |
Net income | -32.59M | 5.73% |
Net profit margin | — | — |
Earnings per share | -0.33 | 32.65% |
EBITDA | -36.38M | 4.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 287.14M | 5.42% |
Total assets | 431.19M | 42.75% |
Total liabilities | 24.27M | -13.55% |
Total equity | 406.92M | — |
Shares outstanding | 97.39M | — |
Price to book | 2.63 | — |
Return on assets | -23.57% | — |
Return on capital | -24.57% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -32.59M | 5.73% |
Cash from operations | -25.11M | 12.80% |
Cash from investing | -110.54M | -579.13% |
Cash from financing | 109.45M | 86,765.87% |
Net change in cash | -26.20M | -367.70% |
Free cash flow | -14.78M | 10.70% |
About
Founded
2014
Headquarters
Website
Employees
106
